We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » While 'Incomplete,' GAO Report May Ensure Legislative Reforms to FDA Drug Reviews
While 'Incomplete,' GAO Report May Ensure Legislative Reforms to FDA Drug Reviews
April 28, 2006
A Government Accountability Office (GAO) report on shortfalls in the FDA’s drug review protocols did not go far enough in recommending changes, but it still may provide the momentum for dormant legislative reforms to become law, sources say.